are endangering Ukraine’s world-leading medicinal chemistry industry, which supplies scientists across the globe with molecular building blocks needed for early drug development.
Ukraine’s dominance in medicinal chemistry is little known beyond drug developers, who fine-tune a drug’s molecular design to give it the best chance of hitting the desired biological target in the body. Kyiv-based Enamine Ltd. has become a go-to supplier for drug-discovery scientists at academic laboratories and the largest pharmaceutical companies.
Simple, let's just bring the scientists and their families here until this thing is over.
Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite: